• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3058
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Unspecified Infection (1930); Device Overstimulation of Tissue (1991); Staphylococcus Aureus (2058); Sepsis (2067); Therapeutic Effects, Unexpected (2099); Urinary Retention (2119); Urinary Tract Infection (2120); Complaint, Ill-Defined (2331); Malaise (2359); Test Result (2695)
Event Date 03/26/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from the consumer regarding a patient with an implantable neurostimulator (ins).It was reported that the patient received a replacement antenna today.It was noted that ¿things were not working properly¿ for the patient so "they switched the pt to program 1 to 1.7v from program 3 at 1.1v".It was noted the implantable neurostimulator (ins) was implanted in their right upper buttocks.The patient also noted that last tuesday "they stopped it" and they went back to their healthcare professional (hcp) yesterday where ¿they restarted it¿ (no further clarification given).In addition, the patient stated that, today, ¿she was not feeling right¿ and was sick.The patient continued, stating that ¿i got the device and it¿s been absolutely amazing for me, but my infections have become more frequent¿.It was noted that their infection ¿my infection last time, it was so bad, i had sepsis, staph, and (b)(6), so i was 10 days receiving 2 infusions a day at the hospital, so they want me to go to the (b)(6) clinic¿.They mentioned that they "thought she was going to die".These issues were reported as starting the last week of (b)(6).Further, it was reported that their healthcare professional (hcp) did not know if the patient was ¿being overstimulated¿.This concern started a week ago today.The patient again stated they were originally on program 3 at 1.1 volts and then was moved to program 1 at 1.7 volts by the pac in (b)(6).It was noted their hpc wanted them between 1.0 and 1.1.The patient was able to use their programmer and synchronize it to the implantable neurostimulator (ins) where they saw that program 1 was checked, was at 1.7 volts, but could not see the ¿lightning bolt¿ to verify the therapy was on.Follow up information received from the healthcare professional (hcp) on may 1, 2018 reported that, regarding the ¿things were not working properly¿ and ¿they restarted it¿ was clarified that they were concerned that elevated ¿pvr¿ (post-void residual?) was due to overstimulation.As a result, they turned the device off for a week and the ¿pvr¿ became normal.The cause of the ¿things were not working properly¿/overstimulation concerns was not determined.The ¿things were not working properly¿ (having to restart) issue was resolved ¿due to new remote¿.The patient¿s infection issue was clarified that they had recurrent urinary tract infections (uti) and that the patient thought they were refluxing urine.Prior to implant of the device, the patient had no utis but it was noted they had a ureter transplant.The hcp was still evaluating the cause of the patient¿s uti.It was noted that the uti was related to the patient¿s underlying urinary dysfunction and was possibly related to the ins device/therapy ¿causing higher residual¿.As an action/intervention for the uti, the patient was given low dose, long term macrobid therapy.It was unknown if the uti issue was resolved as the patient had just begun a 6 month trial.There were no further complications reported or anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Follow-up with the patient's healthcare provider (hcp) determined that the patient has a history of recurrent utis, and it was unknown if the current uti was related to the patient's underlying urinary dysfunction.No additional information was available from the hcp at the time of this report.There were no further complication reported or anticipated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM II
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7482905
MDR Text Key107218661
Report Number3004209178-2018-09959
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00613994913654
UDI-Public00613994913654
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 06/15/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/28/2016
Device Model Number3058
Device Catalogue Number3058
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/24/2018
Initial Date FDA Received05/03/2018
Supplement Dates Manufacturer Received06/07/2018
Supplement Dates FDA Received06/15/2018
Date Device Manufactured04/28/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age50 YR
Patient Weight54
-
-